ABCL — AbCellera Biologics Inc
On NASDAQ, AbCellera Biologics Inc trades as ABCL.
It operates in the HEALTHCARE sector (BIOTECHNOLOGY).
If you are here to check AbCellera Biologics Inc before deciding, you get an interactive chart, momentum and risk scores, current headlines and alerts you can set on ABCL.
The scores shown here come from a model trained on real market data across seven technical indicators; it estimates both the probability of a rise and the level of risk, and shows both openly.
What ABCL is
AbCellera Biologics Inc. develops an antibody discovery platform. The company is headquartered in Vancouver, Canada.…
AbCellera Biologics Inc is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
It trades on NASDAQ as a common stock.
ABCL size and valuation
At roughly $4.26B, ABCL is a mid-cap.
Earnings per share are negative at -0.54, so there is no meaningful price-to-earnings multiple to quote.
Beta is 1.41: historically it has moved more than the market.
ABCL over the past year
Over the past year ABCL has traded between $2.75 and $15.02, and the current price sits at 74% of that range.
The 50-day average is $10.70 against a 200-day average of $6.03 — the shorter average sits above the longer one, the configuration usually read as an uptrend.
The published analyst target is $16.70, 40.6% above it. A target is an aggregate of opinions, not a measurement.
How AbCellera Biologics Inc (ABCL) is trading
AbCellera Biologics Inc (ABCL) is up 6.74% at $11.88. A move that large in a single session sits well outside the normal daily range for most stocks.
The session ranged from $11.20 to $11.98 — 6.6% of the share price — and the current price sits at 87% of that range.
It opened at $11.56 against a previous close of $11.13 — an opening gap of +3.9%, which almost always comes from information released outside trading hours.
The day's range extended past the previous close ($11.13) on both sides.
Volume ran near 2.2M shares, about $26.3M of stock changing hands.
Traded alongside ABCL
Names traded alongside ABCL in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABEO (Abeona Therapeutics Inc), ABOS (Acumen Pharmaceuticals Inc).
What VAQO's model says about ABCL
Two statistical models run over ABCL inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.
Instrument details
- Symbol: ABCL
- Name: AbCellera Biologics Inc
- Sector: HEALTHCARE
- Industry: BIOTECHNOLOGY
- Exchange: NASDAQ
- Instrument: Stock
ABCL — frequently asked questions
What is the market cap of ABCL?
AbCellera Biologics Inc has a market capitalisation of roughly $4.26B.
What is the 52-week range for ABCL?
ABCL has traded between $2.75 and $15.02 over the past year, with the current price at 74% of that range.
How much does ABCL stock cost today?
AbCellera Biologics Inc (ABCL) trades at $11.88, a change of +6.74% in the latest session.
Is ABCL up or down today?
ABCL is up 6.74% in the latest session, at $11.88.
What is the daily trading range for ABCL?
ABCL traded between $11.20 and $11.98 in the latest session, and currently trades at $11.88.
What is the trading volume for ABCL?
ABCL traded roughly 2.2M shares in the latest session.
Which exchange is ABCL listed on?
ABCL is listed on NASDAQ, in the HEALTHCARE sector.
Should I buy ABCL stock?
VAQO gives no buy or sell recommendations and is not an investment adviser. The ABCL figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.
More HEALTHCARE stocks
- A — Agilent Technologies Inc
- AAPG — Ascentage Pharma Group International
- AARD — Aardvark Therapeutics Inc
- ABEO — Abeona Therapeutics Inc
- ABOS — Acumen Pharmaceuticals Inc
- ABSI — Absci Corp
Last updated: 2026-11-08